How many insider trades does FilingIQ track for ENZND?

FilingIQ tracks 3 Form 4 insider transactions for ENZND (Viskase Holdings, Inc.), covering filings from Mar 25, 2026 onwards. 3 of those were filed in the last 90 days.

Are ENZND insiders net buyers or net sellers?

Across the full Form 4 history for ENZND, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ENZND insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ENZND in?

Viskase Holdings, Inc. (ENZND) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.08M.

ENZND insider trading

OTC Markets OTCQB Healthcare

Viskase Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$4.08M

About Viskase Holdings, Inc.

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

Company website: enzon.com

ENZND insider activity at a glance

FilingIQ has scored 3 insider transactions for ENZND since Mar 25, 2026. The most recent filing in our index is dated Mar 26, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live ENZND trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ENZND?: FilingIQ tracks 3 Form 4 insider transactions for ENZND (Viskase Holdings, Inc.), covering filings from Mar 25, 2026 onwards. 3 of those were filed in the last 90 days.
Are ENZND insiders net buyers or net sellers?: Across the full Form 4 history for ENZND, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ENZND insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ENZND in?: Viskase Holdings, Inc. (ENZND) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.08M.

Methodology & sources

Every ENZND insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.